Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

To draw attention to severe presentations of atypical neuroleptic related diabetes and to document that a marked degree of remission can take place after drug withdrawal.We describe two patients who presented with diabetic ketoacidosis after treatment with quetiapine and risperidone, respectively.Both patients were negative for islet cell antibodies. They both required treatment with insulin, one in very high dosage, but their insulin requirements fell progressively after the atypical antipsychotic was withdrawn. After several months, neither patient required antidiabetic treatment.Atypical antipsychotic-induced diabetes does not always take a "type 2" presentation in which weight gain and insulin resistance are implicated. Sometimes the presentation is with diabetic ketoacidosis, requiring insulin treatment, which can nevertheless be reversible.

Original publication




Journal article


International journal of psychiatry in medicine

Publication Date





307 - 311


Fulbourn Hospital, Cambridge, UK.


Humans, Diabetes Mellitus, Type 2, Metformin, Risperidone, Dibenzothiazepines, Antipsychotic Agents, Hypoglycemic Agents, Severity of Illness Index, Schizophrenia, Adult, Middle Aged, Female, Male, Quetiapine Fumarate